NCT00810732 - Effects Of Sitaxsentan On Proteinuria, 24-Hour Blood Pressure, And Arterial Stiffness In Chronic Kidney Disease Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 9, 2007

Primary Completion Date

March 6, 2009

Study Completion Date

March 6, 2009

Conditions

Chronic Kidney Disease

Interventions

DRUG

Open

Sitaxsentan sodium 100 mg orally administered once daily (double blind arm)

DRUG

Nifedipine

Nifedipine = 30 mg extended release tablets, orally administered once daily (open label arm)

DRUG

Placebo

Placebo for sitaxsentan, orally administered once daily (double blind arm)

Trial Locations (2)

Clinical Research Centre and Pharmacology Unit, Edinburgh

the University of Edinburgh, Western General Hospital, Department of Medical Sciences, Edinburgh